health_en

FDI World Dental Federation: Prescribing of dental antibiotics up 22% in England during first year of COVID-19

Prescriptions of all other antibiotics fell during the same period After years of consecutive decline, the rate of dental antibiotic prescribing increased by over a fifth in 2020 due to COVID-19 restrictions. Dentistry was the only part of England’s publicly-funded National Health Service to experience an increase. The steepest rise occurred when dental practices were […]

thaipr.net

18 พ.ย. 64

Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that European Medicines Agency (EMA) has begun its evaluation of an application for conditional marketing authorization (CMA) for Novavax’ COVID-19 vaccine, which will be marketed in the European Union under the brand name Nuvaxovid™. EMA’s statement […]

thaipr.net

18 พ.ย. 64

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

– Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care – Top-line results for Part A of the study, designed to evaluate safety and tolerability of RHB-107 and dose selection, expected in Q1/ 22 – RHB-107 is a novel, investigational antiviral […]

thaipr.net

17 พ.ย. 64

Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

SK bioscience submits application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for BLA, to South Korea’s MFDS Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK bioscience), a biotechnology company in South Korea, today announced the submission of a Biologics […]

thaipr.net

16 พ.ย. 64

AstraZeneca discloses the making and quality assuring of COVID-19 vaccine manufactured in Thailand

The Emergency Use Listing (EUL) authorisation has recently been granted by the World Health Organization (WHO) to AstraZeneca’s COVID-19 vaccine manufactured in Thailand by Siam Bioscience and recognises that COVID-19 Vaccine AstraZeneca or Vaxzevria is the same product wherever it is made. AstraZeneca today reveals manufactured by its production partner in Thailand Siam Bioscience who […]

thaipr.net

15 พ.ย. 64

Ascensia Diabetes Care Announce Winner of This is Diabetes Art and Photo Competition

Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributors of the Eversense® continuous glucose monitoring (CGM) system, has announced the winner of its This is Diabetes art and photo competition. The competition was looking for a piece of artwork or photography that reflected “Access to Diabetes Care”, […]

thaipr.net

15 พ.ย. 64

Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings. Jubilant Biosys provides services for Turning Point Therapeutics Inc. for multiple small molecule oncology research programs. Turning Point is a precision oncology company developing next-generation therapies that target genetic drivers of cancer. Services for Turning Point Therapeutics Inc. […]

thaipr.net

15 พ.ย. 64
1 … 89 90 91 92 93 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.